O’Sullivan A et al (2011) Cost Estimation of Cardiovascular Disease Events in the US. Pharmacoeconomics 29(8):693–704O’Sullivan AK, Rubin J, Nyambose J, Kuznik A, Cohen DJ, Thompson D. Cost estimation of cardiovascular disease events in the US . Pharmacoeconomics . 2011; 29 :693-...
Cost-effectiveness analysis of interventions to prevent cardiovascular disease in Vietnam Vietnam is in the process of an epidemiological transition, with cardiovascular disease (CVD) now ranked as the leading cause of death. The burden of CVD w... HD Anh,C Dan - 《Health Policy & Planning》...
- 《Heart Official Journal of the British Cardiac Society》 被引量: 177发表: 2006年 Accounting for the cost of US health care: A new look at why Americans spend more Objective: To estimate the economic burden of cardiovascular disease (CVD) in the United Kingdom, including health and non-...
Cost effectiveness of carvedilol for heart failure. Am J Cardiol. 1999;83(6):890-896. doi:10.1016/S0002-9149(98)01066-2 PubMedGoogle ScholarCrossref 7. Gaziano TA. Cardiovascular disease in the developing world and its cost-effective management. Circulation. 2005;112(23):...
Comparing the cost-effectiveness of four novel risk markers for screening asymptomatic individuals to prevent cardiovascular disease (CVD) in the US population. Int J Cardiol. 2016;203:422-431. doi:10.1016/j.ijcard.2015.10.171 PubMedGoogle ScholarCrossref 11. Pletcher MJ, Pignone ...
Both total and disease-specific costs are similar in The Netherlands and Sweden, but differ from those in the US. The available data suggest that the differences in medical practice and health care systems may explain a substantial part of the divergent results; demographic or epidemiologic aspects...
Cerebrovascular disease cost the EU €34 billion in 2003. From 2005 to 2050 the anticipated cost of stroke to the US economy is estimated at US$2.2 ... RWV Flynn,RSM Macwalter,ASF Doney - 《Neuropharmacology》 被引量: 393发表: 2008年 Clinical outcomes, quality of life, and costs in the...
Individual programs for prevention of cardiovascular disease include dietary and drug treatment of hypercholesterolemia, hypertension treatment, and smoking cessation therapies. In this study, the cost-effectiveness of available cardiovascular prevention programs was assessed in Spain in terms of net cost per...
Health economic assessments provide a model to estimate the potential influence on costs associated with changes in chronic disease risk resulting from improved diet quality in the US adult population. Objective: To estimate the impact on health care costs associated with increased conformance with the...
“The burden of cardiovascular disease is growing faster than our ability to combat it, and our new report indicates it could get much worse in the coming years,” Houser said. Total heart disease costs across all conditions are projected to more than triple among people aged 80 or older. ...